Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1500198 · FYE Sep 30 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.67Day −5.11%Mkt cap $67M1Y −67.3%Off 52W high −76.0%Vol (1Y) 74.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,946 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$9.2M |
| Earnings (TTM)-$6.9M |
| ROE−91.3% |
| Net margin−39.6% |
| Sales growth 3Y276.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−63.2% |
| 1Y−67.3% |
| 3Y−72.9% |
| 5Y−93.8% |
| Since incept. (ann.)−34.2% |
Total return through 2026-07-28 · series begins 2017-08-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)74.6% |
| Ann. volatility (3Y)85.1% |
| Sharpe (1Y)−1.16 |
| Sharpe (3Y)−0.07 |
| Max drawdown (1Y)−73.7% |
| Max drawdown (3Y)−85.5% |
| Beta (3Y vs SPY)1.13 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SBI Securities Co., Ltd. | 20 | $16 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.28 | — | $1.9M | +34.3% |
| 2025-12-31 | 2026-02-17 | −$0.03 | −150.0% | $2.9M | −11.7% |
| 2025-09-30 | 2025-12-17 | — | — | $2.7M | +906.6% |
| 2025-06-30 | 2025-08-14 | −$0.03 | — | $1.7M | +105.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
One RFAblation System Revenue 100%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
